Clinical Trials Browser

Familial ependymoma, Ovarian Germ Cell Cancer, Testicular Germ Cell Tumor, Astrocytoma, Burkitt Lymphoma, Carcinoma, Renal Cell, Immunoblastic Lymphadenopathy, Kidney Neoplasms, Liver Neoplasms, Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Recurrence, Sarcoma, Osteosarcoma, Spinal Cord Neoplasms, Teratoma, Testicular Neoplasms, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Nephroma, Mesoblastic, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT05277688 2022-09-16

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Phase 3 Recruiting

340 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms, HIV Infections

NCT05310383 2022-04-11

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Phase 2 Unknown

58 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03977311 2022-04-01

MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer

Phase NA Withdrawn

Gynecologic

Locally Advanced Cervical Cancer

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Phase 3 Unknown

813 enrolled 14 charts

Gynecologic

Endometrial Clear Cell Adenocarcinoma

NCT04884906 2021-05-13

Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

Phase 2 Unknown

40 enrolled

Gynecologic

Locally Advanced Cervical Cancer

NCT04664244 2020-12-22

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Phase 2 Unknown

43 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00006027 2020-10-22

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

Phase 3 Completed

Gynecologic

Endometrial Neoplasms

NCT00231868 2020-08-12

A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma

Phase 2 Completed

81 enrolled 4 charts

Gynecologic

Uterine Neoplasms

NCT00002807 2020-04-06

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Phase NA Completed

116 enrolled

Gynecologic

Endometrial Neoplasms

NCT03146039 2020-02-05

NICER

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Cisplatin+Pembrolizumab+RT in Vulvar Cancer

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

ATEZOLACC

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

GEMCOL

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

RETHEMCOL

NELCER

BEFORE

Serplulimab for Locally Advanced Cervical Cancer

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Toripalimab for High-risk Locally Advanced Cervical Cancer

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

NiCOL

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

IMMUVIX

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

PARCERII

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

INTERLACE

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

PORTEC-3

ONCOCOL01

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

APX005M

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

NICER